(VIANEWS) – ELIS (ELIS.PA), SPAREBANKEN MØRE (MORG.OL), ING GROEP N.V. (INGA.AS) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. ELIS (ELIS.PA)
77.2% sales growth and 6.57% return on equity
Elis SA provides flat linen, workwear, and hygiene and well-being solutions in France, Central Europe, Scandinavia, Eastern Europe, the United Kingdom, Ireland, Latin America, Southern Europe, and internationally. The company offers table, bed, kitchen, patient, and bath linens; workwear and personal protective equipment; beverage solutions, such as water coolers and accessories, cups and bottles, and coffee machines; floor protection mats and mops; industrial wipers; and pest and rodent control, insect control, or disinfection services. It also provides washroom hygiene services, such as hand washing and drying, toilet hygiene and urinals, lavatories, and air fragrancing; and reusable cleanroom garments, footwear, goggles, and related contamination control solutions, as well as cleaning systems. In addition, the company offers various solutions for collection and disposal of infectious waste, as well as laundry facilities. It primarily serves the catering, accommodation, healthcare and social welfare, industries, trade and retail, and services sectors, as well as public authorities and administration. Elis SA was founded in 1883 and is headquartered in Saint-Cloud, France.
Earnings Per Share
As for profitability, ELIS has a trailing twelve months EPS of €0.86.
PE Ratio
ELIS has a trailing twelve months price to earnings ratio of 19.48. Meaning, the purchaser of the share is investing €19.48 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.57%.
More news about ELIS.
2. SPAREBANKEN MØRE (MORG.OL)
34.3% sales growth and 10.71% return on equity
Sparebanken Møre, together with its subsidiaries, provides banking services for retail and corporate customers in Norway. It operates through Retail and Real Estate Brokerage segments. The company offers services in the areas of financing, deposits and other forms of investments, payment transfers, financial advisory services, asset management, insurance, and real estate brokerage. Sparebanken Møre was founded in 1843 and is headquartered in Ålesund, Norway.
Earnings Per Share
As for profitability, SPAREBANKEN MØRE has a trailing twelve months EPS of kr15.67.
PE Ratio
SPAREBANKEN MØRE has a trailing twelve months price to earnings ratio of 4.83. Meaning, the purchaser of the share is investing kr4.83 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.71%.
Moving Average
SPAREBANKEN MØRE’s value is under its 50-day moving average of kr78.18 and under its 200-day moving average of kr77.11.
More news about SPAREBANKEN MØRE.
3. ING GROEP N.V. (INGA.AS)
24.2% sales growth and 25.17% return on equity
ING Groep N.V., a financial institution, provides various banking products and services in the Netherlands, Belgium, Rest of Europe, North America, Latin America, Asia, and Australia. It operates in six segments: Retail Netherlands, Retail Belgium, Retail Germany, Retail Other, Wholesale Banking, and Corporate Line Banking. The company accepts various deposits, such as current and savings accounts. It also offers business lending products; consumer lending products, such as residential mortgage loans, term loans, and other consumer lending loans; and secured and unsecured lending services. in addition, the company provides debt capital market, working capital solutions, export finance, daily banking, treasury and risk, and corporate finance solutions; and specialized lending, debt and equity market solutions, payments and cash management, and trade and treasury services, as well as savings, investment, insurance, mortgage, and digital banking services; and SME loans. It serves individual customers, corporate clients, and financial institutions. ING Groep N.V. was founded in 1762 and is headquartered in Amsterdam, the Netherlands.
Earnings Per Share
As for profitability, ING GROEP N.V. has a trailing twelve months EPS of €1.34.
PE Ratio
ING GROEP N.V. has a trailing twelve months price to earnings ratio of 8.91. Meaning, the purchaser of the share is investing €8.91 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 25.17%.
Moving Average
ING GROEP N.V.’s value is higher than its 50-day moving average of €11.38 and higher than its 200-day moving average of €11.14.
Revenue Growth
Year-on-year quarterly revenue growth grew by 51.8%, now sitting on 31.29B for the twelve trailing months.
Volume
Today’s last reported volume for ING GROEP N.V. is 1722190 which is 89.15% below its average volume of 15886600.
More news about ING GROEP N.V..
4. AIRBUS (AIR.PA)
14.7% sales growth and 53.48% return on equity
Airbus SE engages in the design, manufacture, and delivery of aerospace products, services, and solutions worldwide. It operates through three segments: Airbus, Airbus Helicopters, and Airbus Defence and Space. The Airbus segment develops, manufactures, markets, and sells commercial jet passenger aircraft; freighter aircraft; and regional turboprop aircraft and aircraft components, as well as provides aircraft conversion and related services. The Airbus Helicopters segment engages in the development, manufacture, marketing, and sale of civil and military helicopters; and provision of helicopter related services. The Airbus Defence and Space segment designs, develops, delivers, and supports military aircraft, such as combat, mission, transport, tanker aircraft, and their associated services; a range of civil and defence space systems for telecommunications, earth observations, navigation, science, and orbital systems; and unmanned aerial systems. This segment also offers missile and space launcher systems, as well as services around data processing from platforms, secure communication, and cyber security. The company was formerly known as Airbus Group SE and changed its name to Airbus SE in April 2017. Airbus SE was incorporated in 1998 and is based in Leiden, the Netherlands.
Earnings Per Share
As for profitability, AIRBUS has a trailing twelve months EPS of €4.47.
PE Ratio
AIRBUS has a trailing twelve months price to earnings ratio of 28.01. Meaning, the purchaser of the share is investing €28.01 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 53.48%.
Yearly Top and Bottom Value
AIRBUS’s stock is valued at €125.22 at 12:20 EST, under its 52-week high of €126.04 and way above its 52-week low of €86.52.
Volume
Today’s last reported volume for AIRBUS is 109127 which is 89.24% below its average volume of 1014990.
More news about AIRBUS.
5. NAVAMEDIC (NAVA.OL)
9.6% sales growth and 22.97% return on equity
Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Northern Europe. The company's product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics. It offers medical nutrition products for various therapeutic areas, including phenylketonuria, homocystinuria, maple syrup urine disease, tyrosinemia, methylmalonic acidemia/propionic acidemia, glutaric aciduria, isovaleric acidemia, and urea cycle disorders, as well as products for glycogen storage diseases and renal diseases, fat metabolism, malnutrition, and ketogenic diet. In addition, the company provides consumer health products consisting of non-prescription drugs and health care products for pain relief, cough and cold, gastro, obesity, women's health, and others primarily through pharmacies and drugstores; specialty pharmaceutical products in various therapeutic areas comprising dermatology, wound care, urology, and obesity; and branded generics, including cardiology products and antibiotics. It sells, markets, and distributes its products to hospitals, patients, and pharmacies. The company was formerly known as Glucomed AS and changed its name to Navamedic ASA in 2004. Navamedic ASA was incorporated in 2002 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, NAVAMEDIC has a trailing twelve months EPS of kr1.72.
PE Ratio
NAVAMEDIC has a trailing twelve months price to earnings ratio of 21.92. Meaning, the purchaser of the share is investing kr21.92 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 22.97%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 93.3%, now sitting on 440.93M for the twelve trailing months.
Yearly Top and Bottom Value
NAVAMEDIC’s stock is valued at kr37.70 at 12:20 EST, way under its 52-week high of kr43.60 and way higher than its 52-week low of kr25.00.
Sales Growth
NAVAMEDIC’s sales growth is 93.3% for the present quarter and 9.6% for the next.
Volume
Today’s last reported volume for NAVAMEDIC is 25097 which is 4.76% below its average volume of 26352.
More news about NAVAMEDIC.
6. ORKLA (ORK.OL)
8% sales growth and 12.65% return on equity
Orkla ASA engages in branded consumer goods, and industrial and financial investment businesses. The company offers branded products, including frozen pizza, ketchup, soups, sauces, bread toppings, and ready-to-eat meals through grocery channels, as well as food service, convenience stores, and petrol stations. It also provides confectionery, biscuit, and snack products; and develops bran and crispbread products, as well as energy snack meals. In addition, the company offers personal care and cleaning products; dietary supplement, sport nutrition, and weight control products; wound care products and first aid equipment; painting tools; basic and wool garments for men, women, and children; and professional cleaning products. Further, it operates Gymgrossisten, Proteinfabrikken, Bodystore, and Fitnessmarket e-commerce portals for health and sports nutrition products; and restaurants. Additionally, the company supplies margarine and butter blends, bread and cake improvers and mixes, yeast, marzipan, and ice cream ingredients; produces and supplies hydro power to the Nordic power market; and develops and sells real estate properties. It offers its food products under the Grandiosa, TORO, Stabburet, Felix, Paulúns, NATURLI', Abba, Beauvais, Den Gamle Fabrik, Spilva, and Vitana brands; confectionery and snacks under the KiMs, Nidar, Stratos, Sætre, Göteborgs Kex, OLW, Panda, Laima, Selga, Taffel, Kalev, and Nói Síríus brands; health and sports nutrition under e Zalo, Jif, Bliw, Grumme, Blenda, Define, Möller's, Collett, Nutrilett, Maxim, Norgesplaster, and Salvequick brands; and food ingredients under the Odense, Mors Hjemmebakte, KronJäst, Bakkedal, and NATURLI brands. It has operations in Norway, Sweden, Denmark, Finland, Iceland, the Baltics, rest of Europe, and internationally. The company was founded in 1918 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, ORKLA has a trailing twelve months EPS of kr5.26.
PE Ratio
ORKLA has a trailing twelve months price to earnings ratio of 15.46. Meaning, the purchaser of the share is investing kr15.46 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.65%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 22%, now sitting on 61.31B for the twelve trailing months.
Moving Average
ORKLA’s worth is higher than its 50-day moving average of kr76.33 and higher than its 200-day moving average of kr74.69.
Yearly Top and Bottom Value
ORKLA’s stock is valued at kr81.30 at 12:20 EST, under its 52-week high of kr85.20 and way above its 52-week low of kr67.06.
Volume
Today’s last reported volume for ORKLA is 81893 which is 92.63% below its average volume of 1111190.
More news about ORKLA.
